Related Experiment Videos
Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study.
Saleh Abdelhamid1, Roland Blomer, Gerhard Hommel
1Hypertension and Nephrology Unit, Deutsche Klinik für Diagnostik and Klaus Ketzler Institute, Wiesbaden, Aukammallee, Germany. abdelham@mail.uni-mainz.de
American Journal of Hypertension
|July 10, 2003
Summary
Tetrahydroaldosterone is the most reliable screening test for primary aldosteronism (PA), outperforming traditional markers. Combining it with other metabolites enhances diagnostic accuracy for PA.
Area of Science:
- Endocrinology
- Clinical Diagnostics
- Hypertension Research
Background:
- Aldosterone secretion is primarily reflected by its metabolite, 3 alpha,5 beta tetrahydroaldosterone.
- Urinary tetrahydroaldosterone excretion may accurately indicate daily aldosterone production and serve as a primary aldosteronism (PA) indicator.
Purpose of the Study:
- To evaluate tetrahydroaldosterone as a screening test for PA.
- To compare its diagnostic performance against established biomarkers for PA.
Main Methods:
- Prospective study involving 111 normotensive individuals, 412 PA patients, and 1453 essential hypertensive patients.
- Assessed tetrahydroaldosterone, serum potassium, plasma aldosterone, plasma renin activity, plasma aldosterone/renin activity ratio (PARR), urinary aldosterone-18-glucuronide, and free aldosterone.
- Investigated the impact of blood sampling technique on potassium levels.
Main Results:
- Tetrahydroaldosterone demonstrated 96% sensitivity and 95% specificity for differentiating PA from essential hypertension.
- It significantly outperformed plasma aldosterone, free aldosterone, PARR, aldosterone-18-glucuronide, and renin activity in sensitivity.
- Forearm exercise was identified as a factor causing erroneous potassium elevations, potentially obscuring PA diagnosis.
Conclusions:
- Tetrahydroaldosterone is identified as the most reliable screening test for PA.
- Combining tetrahydroaldosterone with aldosterone-18-glucuronide and free aldosterone improves diagnostic specificity for PA.
- Traditional screening methods (potassium, renin, plasma aldosterone, basal PARR) are deemed inadequate due to high false-positive/negative rates.